Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19

出版年份 2020 全文链接

标题

作者

关键词

Covid-19, SARS-CoV-2, Melatonin, Obesity, Diabetes mellitus, Inflammation

出版物

Volume 882, Issue -, Pages 173329

出版商

Elsevier BV

发表日期

2020-06-30

DOI

10.1016/j.ejphar.2020.173329

联系作者

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now